Enzyme revealed as promising new target for cancer immunotherapies
A new study has highlighted an enzyme called ART1 as a promising target for immunity-boosting cancer treatments.
List view / Grid view
A new study has highlighted an enzyme called ART1 as a promising target for immunity-boosting cancer treatments.
A new study has highlighted that gene expression profiling could enable rapid identification of anti-tumour immune cells for personalised immunotherapy.
A next-generation spatial genomics technology has allowed scientists to link specific genes to complex tumour characteristics at a scale and resolution not previously possible.
Using CRISPR gene-editing technology, scientists have developed a vaccine designed to prevent infection by Leishmania major.
Researchers have shown that it could be possible to modify the mitochondrial genome, paving the way for new treatments for incurable mitochondrial diseases.
Researchers have been able to significantly reduce tumours in a pre-clinical model of a rare genetic lung disease.
Scientists from Northwestern University have developed a new technology platform that could bring individualised cell therapies to cancer patients.
Sino Biological, Inc. has announced the formation of two new operationally focused subsidiaries in China.
A new study on substance abuse disorders highlights an existing connection between specific neurons and peripheral organs.
Researchers from the University of Pennsylvania may have discovered how to eliminate the risk of weight gain from certain diabetes medications by uncovering the difference between two varieties of a protein.
A new study led by the Indiana University School of Medicine showed human induced pluripotent stem cells can improve visual acuity, vascular health and other complications related to type 2 diabetes.
A new study has showed how a bioengineered RSV protein vaccine can induce a protective immune response in animal models.
Scientists have found a way to “supercharge” tumour-attacking T cells, which could improve the effectiveness of cell-based cancer immunotherapy and expand the number of cancers it can treat.
New research by UC Riverside may be a crucial step in the design of engineered nano-shells that could serve as vehicles for delivering drugs to specific targets in the body.
Researchers at Texas A&M University have applied organ-on-chip models to the lymph system to create the first lymphangion-chip.